1. Home
  2. BFIN vs URGN Comparison

BFIN vs URGN Comparison

Compare BFIN & URGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFIN
  • URGN
  • Stock Information
  • Founded
  • BFIN 1924
  • URGN 2004
  • Country
  • BFIN United States
  • URGN United States
  • Employees
  • BFIN N/A
  • URGN N/A
  • Industry
  • BFIN Savings Institutions
  • URGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • BFIN Finance
  • URGN Health Care
  • Exchange
  • BFIN Nasdaq
  • URGN Nasdaq
  • Market Cap
  • BFIN 153.0M
  • URGN 181.2M
  • IPO Year
  • BFIN N/A
  • URGN 2017
  • Fundamental
  • Price
  • BFIN $11.60
  • URGN $14.82
  • Analyst Decision
  • BFIN
  • URGN Strong Buy
  • Analyst Count
  • BFIN 0
  • URGN 9
  • Target Price
  • BFIN N/A
  • URGN $26.81
  • AVG Volume (30 Days)
  • BFIN 20.4K
  • URGN 5.9M
  • Earning Date
  • BFIN 07-30-2025
  • URGN 08-12-2025
  • Dividend Yield
  • BFIN 3.47%
  • URGN N/A
  • EPS Growth
  • BFIN N/A
  • URGN N/A
  • EPS
  • BFIN 0.36
  • URGN N/A
  • Revenue
  • BFIN $48,547,000.00
  • URGN $91,871,000.00
  • Revenue This Year
  • BFIN $1.43
  • URGN $36.65
  • Revenue Next Year
  • BFIN $4.33
  • URGN $88.35
  • P/E Ratio
  • BFIN $32.05
  • URGN N/A
  • Revenue Growth
  • BFIN N/A
  • URGN 8.98
  • 52 Week Low
  • BFIN $9.72
  • URGN $3.42
  • 52 Week High
  • BFIN $13.97
  • URGN $18.15
  • Technical
  • Relative Strength Index (RSI)
  • BFIN 44.89
  • URGN 73.80
  • Support Level
  • BFIN $11.26
  • URGN $6.92
  • Resistance Level
  • BFIN $11.88
  • URGN $15.22
  • Average True Range (ATR)
  • BFIN 0.25
  • URGN 1.57
  • MACD
  • BFIN -0.02
  • URGN 1.17
  • Stochastic Oscillator
  • BFIN 39.88
  • URGN 96.49

About BFIN BankFinancial Corporation

BankFinancial Corp is a full-service, national bank providing banking, financial planning and fiduciary services to individuals, families and businesses in the Chicago metropolitan area and on a regional or national basis for commercial finance, healthcare finance, equipment finance, commercial real estate finance and treasury management business customers. The Bank offers its customers a broad range of loan, deposit, trust and other financial products and services through approximately 18 full-service banking offices located in Cook, DuPage, Lake and Will Counties, Illinois and through its Internet Branch.

About URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical-stage biotechnology firm specializing in solutions for urothelial and specialty cancers. The company has developed RTGel reverse-thermal hydrogel, a proprietary technology enhancing the therapeutic profiles of existing drugs by enabling sustained release. Their flagship product, Jelmyto (mitomycin) for pyelocalyceal solution, along with investigational candidate UGN-102 (mitomycin) for intravesical solution, targets non-surgical tumor ablation in forms of non-muscle invasive urothelial cancer. Additionally, their immuno-uro-oncology pipeline includes UGN-301 (zalifrelimab), an anti-CTLA-4 antibody, intended for both monotherapy and combination therapy. Revenue is generated from product sales.

Share on Social Networks: